Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | |
| Operating Expenses | 138,736 | 110,783 | 36,999 | 27,064 |
| Operating Income | -138,736 | -110,783 | -36,999 | -27,064 |
| Interest Expense | 3,581 | 259 | 0 | 0 |
| Other Income | -4,363 | -257 | -38 | 93 |
| Pre-tax Income | -146,680 | -111,299 | -37,037 | -26,970 |
| Income Tax | 65 | 47 | 37 | N/A |
| Net Income Continuous | -146,745 | -111,346 | -37,074 | -26,970 |
| Net Income | $-146,745 | $-111,346 | $-37,074 | $-26,970 |
| EPS Basic Total Ops | -4.82 | -4.43 | -2.16 | -10.10 |
| EPS Basic Continuous Ops | -4.82 | -4.43 | -2.16 | -10.10 |
| EPS Diluted Total Ops | -4.82 | -4.43 | -2.16 | -10.10 |
| EPS Diluted Continuous Ops | -4.82 | -4.43 | -2.16 | -10.10 |
| EPS Diluted Before Non-Recurring Items | -4.71 | -4.43 | N/A | N/A |
| EBITDA(a) | $-138,490 | $-110,603 | $-36,987 | $-27,064 |